Neurosteroids in Cognitive Disorder - From Well-Known Pharmacological Aspects to a Source of Controversy
oraz
03 sie 2020
O artykule
Data publikacji: 03 sie 2020
Zakres stron: 23 - 27
Otrzymano: 25 sty 2019
Przyjęty: 24 lut 2020
DOI: https://doi.org/10.2478/amtsb-2020-0007
Słowa kluczowe
© 2020 Mădălina-Georgiana Bătrînu et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
The nervous system is not just a target organ for synthetic steroids. It is also controlled in a certain manner by steroids synthesized de novo in the brain, at the level of both neurones and glial cells. The impressive recent number of literature studies, clearly demonstrates the presence of enzymes necessary for syntheses of central neurosteroids and also the mechanism by which they act. Neurosteroids play a considerable part as an endogenous modulator of brain function and behaviour processes, and the decrease of their concentration can be associated with the pathophysiology of different neurological diseases accompanied by cognitive disorders such as depression, anxiety, schizophrenia, Alzheimer disease.